54 ShawG
GHK-Cu un trattamento topico, non la soluzione in s
Cognitive Decline and Neurodegenerative Conditions Cognitive decline and neurodegenerative conditions show substantial preclinical evidence across multiple pathologies: Stroke models: BPC-157 given during reperfusion counteracted neuronal damage and produced full functional recovery in spatial memory, motor coordination, and balance tests Parkinsons models: MPTP-induced models showed reduced motor symptoms (tremor, rigidity, akinesia), protection of nigrostriatal dopaminergic neurons, and near-complete prevention of mortality Multiple sclerosis models: Cuprizone-induced demyelination resulted in significantly less brain damage and reduced clinical abnormalities when BPC-157 was given in drinking water or intragastrically Traumatic brain injury: Falling weight model studies demonstrated reduced hemorrhage, decreased brain lacerations and edema, and improved early outcomes These diverse models share common mechanisms

Dapsone : used to treat leprosy, dermatitis and Pneumocystis jirovecii pneumonia 5 Non-antimicrobial sulfonamides include Hydrochlorothiazide and furosemide : act as a diuretic and help control blood pressure Glyburide : used to lower blood sugar levels Celecoxib : a non-steroidal anti-inflammatory drug (NSAID) used to reduce pain and inflammation 4 Mechanism of sulfa drug As competitive inhibitors of the dihydropteroate synthetase (DHPS) enzyme, antibacterial sulfonamides target the bacterial metabolic pathway
However, the severity and duration of side effects can vary depending on the specific treatment and individual patient factors